Home
About Lectranal®
Research
Product supply
About us
FAQ
News
Events
LECTRANAL® MARKETS
Contact us
MERCK INTRODUCES LECTRANAL® IN SOUTH AFRICA
06.10.2010.
Milsing d.o.o. announces a distribution agreement with Merck Consumer Health Care Holding GmbH.
Two companies have enclosed an exclusive distribution agreement to sell Lectranal® under Merck's proprietary brand labels. Lectranal® is patent-pending ingredient derived from Astragalus membranaceus, used in traditional Chinese medicine for centuries. Through innovative design it successfully relieves seasonal allergic rhinitis symptoms as shown in clinical trials. Lectranal® was introduced by Merck in South Africa under the commercial name Iliadin herbal.
Zlatko Buzina, Deputy Director of Milsing d.o.o. said: "After building a successful brand presence in Croatia and several other European countries, we are very enthusiastic to start the cooperation with Merck and believe it will develop favorably for both parties in the future. Lectranal® is an established name with medical professionals and consumers in the markets in which we are present."
The incidence of seasonal allergic rhinitis is on the rise globally and the causes for this are still uncertain. It is estimated more than 80 million Europeans suffer from these allergies and the same trend is observed globally.
Disclaimer | General Conditions Of Use | Privacy Statement | Imprint All rights reserved, Lectranal 2006

This website is intended for business to business communication only.
Distributors of the finished products are responsible for ensuring that the claims made
for and use of their products comply with the regulatory requirements of the location.
Owner of the page takes no responsibility for the misuse of the claims.
Design by: Studio2M       Powered by: CorvusCMS